PRVB Market Cap History



Below is a table of the PRVB market cap history going back to 8/9/2018:

Date PRVB Market Cap
8/9/2018128.86M
11/5/2018136.33M
3/15/201989.29M
5/6/2019147.95M
8/2/2019418.94M
8/13/2019163.33M
11/1/2019324.89M
3/9/2020476.14M
4/1/2020377.41M
5/4/2020511.83M
8/3/2020632.03M
11/2/2020725.87M
2/22/2021981.67M
5/3/2021454.40M
8/2/2021391.66M
11/1/2021414.47M
2/21/2022410.67M
5/2/2022304.83M
8/1/2022299.29M
10/31/2022605.10M
3/20/20232.27B

Also see: PRVB Shares Outstanding History
and PRVB YTD Return
PRVB Historical Market Cap:
+86.31% CAGR
PRVB Historical Market Cap: +86.31% CAGR

Mouse over chart for data details
8/9/2018 ...3/20/2023
Provention Bio is a clinical stage biopharmaceutical company. Co.'s primary asset, TZIELD, is approved to delay the onset of Stage 3 Type 1 Diabetes (T1D) in adult and pediatric patients aged eight years and older with Stage 2 T1D. Co. is also developing TZIELD for use in Stage 3 newly diagnosed T1D patients, for which Co. has an ongoing phase three clinical trial, the PROTECT study. Co.'s product portfolio also include: PRV-3279, which is a humanized bispecific scaffold molecule targeting the B-cell surface proteins, an inhibitory Fc receptor for the treatment of systemic lupus erythematosus and for the prevention of immunogenicity of biotherapeutics such as those used in gene therapy. We show 21 historical shares outstanding datapoints in our PRVB shares outstanding history coverage, used to compute PRVB market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing PRVB market cap history over the course of time is important for investors interested in comparing PRVB's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of PRVB versus a peer is one thing; comparing PRVB market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like PRVB can fluctuate over the course of history. With this page we aim to empower investors researching PRVB by allowing them to research the PRVB market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree PRVB Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Provention Bio (PRVB) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

PRVL Market Cap History
PSNL Market Cap History
PSTI Market Cap History
PSTV Market Cap History
PSTX Market Cap History
PTCT Market Cap History
PTE Market Cap History
PTGX Market Cap History
PTI Market Cap History
PTIE Market Cap History
More Healthcare companies »

 

PRVB Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.